RHYTHM PHARMACEUTICALS, INC. Deferred Revenue
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Deferred Revenue of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-04
- 2026-06-30: Deferred Revenue, Current $0.00.
- 2026-03-31: Deferred Revenue, Current $48.00K.
- 2025-12-31: Deferred Revenue, Current $194.00K.
- 2025-03-13: Deferred Revenue, Current $1.30M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 |
| 2026-03-31 | $48.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $194.00K 10-Q · filed 2026-08-04 |
| 2025-03-13 | $1.30M 10-Q · filed 2026-08-04 |
| 2024-12-31 | $1.29M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.29M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.29M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.29M 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.29M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.29M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $1.43M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.43M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.76M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.31M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $9.44M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $7.00M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |